Name: | Histidine |
---|---|
PubChem Compound ID: | 3651426 |
Description: | An essential amino acid that is required for the production of HISTAMINE. |
Molecular formula: | C6H9N3O2 |
Molecular weight: | 155.155 g/mol |
Name: | Histidine |
---|---|
Name (isomeric): | DB00117 |
Drug Type: | small molecule |
Description: | An essential amino acid that is required for the production of HISTAMINE. |
Synonyms: |
(S)-a-Amino-1H-imidazole-4-propanoic acid; Glyoxaline-5-alanine; Histidine; L-(-)-Histidine; (S)-4-(2-Amino-2-carboxyethyl)imidazole; (S)-alpha-Amino-1H-imidazole-4-propionic acid; (S)-Histidine
|
Category: | Micronutrient, Conditionally Essential Amino Acids, Dietary supplement |
CAS number: | 71-00-1 |
Indication: | The actions of supplemental L-histidine are entirely unclear. It may have some immunomodulatory as well as antioxidant activity. L-histidine may be indicated for use in some with rheumatoid arthritis. It is not indicated for treatment of anemia or uremia or for lowering serum cholesterol. |
---|---|
Pharmacology: | Is found abundantly in hemoglobin; has been used in the treatment of rheumatoid arthritis, allergic diseases, ulcers and anemia. A deficiency can cause poor hearing. |
Mechanism of Action: |
Since the actions of supplemental L-histidine are unclear, any postulated mechanism is entirely speculative. However, some facts are known about L-histidine and some of its metabolites, such as histamine and trans-urocanic acid, which suggest that supplemental L-histidine may one day be shown to have immunomodulatory and/or antioxidant activities. ...
show more » |
Absorption: | Absorbed from the small intestine via an active transport mechanism requiring the presence of sodium. |
Toxicity: | ORL-RAT LD50 > 15000 mg/kg, IPR-RAT LD50 > 8000 mg/kg, ORL-MUS LD50 > 15000 mg/kg, IVN-MUS LD50 > 2000 mg/kg; Mild gastrointestinal side effects. |
Affected organisms: | Humans and other mammals |